Search

everythinglearnresearchcommunity

for

Search:↓

Tudor-SN is important for immune cells, and polyamines can promote hair growth.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Punica granatum leaf extract may help treat skin fibrosis by reducing inflammation and oxidative stress.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

ATP-dependent chromatin remodeling is crucial for skin development and stem cell function.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

New CRISPR/Cas9 variants and nanotechnology-based delivery methods are improving cancer treatment, but choosing the best variant and overcoming certain limitations remain challenges.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

ING5 is crucial for stem cell maintenance and preventing certain cancers.

TGF-β and TNF influence hair follicle cell fate, with TNF being more effective in triggering cell death.

Lgr5 and the vitamin D receptor are key in controlling skin inflammation and tumor risk in mice.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Bioinspired polymers are promising for advanced medical treatments and tissue repair.

Biological therapy boosts the immune system to effectively fight melanoma.

Retinoic acid can either maintain stem cells or make them specialize, depending on the cell type.

LncRNAs may help improve brain cancer treatment and diagnosis.

Basal cell carcinomas in mice can start from hair follicle stem cells and other skin cell types, depending on signaling levels.

The document concludes that recent studies help tell apart desmoplastic trichoepitheliomas from other skin tumors, but more research is needed for clear differentiation.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Adrenal tumors should be considered in Addison's disease if unusual results appear, with surgery as a solution.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.